BNP Paribas Financial Markets
MXCT icon

BNP Paribas Financial Markets’s MaxCyte MXCT Stock Holding History

BNP Paribas Financial Markets’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.2K Sell
18,076
-4,009
-18% -$4K ﹤0.01% 5215
2026
Q1 		$15.5K Sell
22,085
-24,720
-53% -$23.1K ﹤0.01% 5140
2025
Q4 		$72.5K Buy
46,805
+10,534
+29% +$16.8K ﹤0.01% 4521
2025
Q3 		$57.3K Buy
36,271
+10,263
+39% +$17.8K ﹤0.01% 4538
2025
Q2 		$56.7K Buy
26,008
+18,913
+267% +$45.8K ﹤0.01% 4214
2025
Q1 		$19.4K Sell
7,095
-6,423
-48% -$25.3K ﹤0.01% 4545
2024
Q4 		$56.2K Buy
+13,518
New +$51.1K ﹤0.01% 4389

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BNP Paribas Financial Markets's MXCT Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its MaxCyte (MXCT) stake by 18% in Q2 2026, selling an estimated $4K and leaving 18,076 shares worth $22.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5215.

BNP Paribas Financial Markets first reported a position in MXCT in Q4 2024 and has held it in 7 quarters since. The position peaked at $72.5K in Q4 2025. 110 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • BNP Paribas Financial Markets held 18,076 shares of MaxCyte worth $22.2K as of Q2 2026.
  • BNP Paribas Financial Markets sold 4,009 MaxCyte shares in Q2 2026, an estimated $4K.
  • MaxCyte made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5215 holding.
  • BNP Paribas Financial Markets first reported a position in MaxCyte in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's MaxCyte position peaked at $72.5K in Q4 2025.
  • 110 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.